Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2?
Author:
Publisher
Elsevier BV
Subject
Biological Psychiatry,Psychiatry and Mental health
Reference14 articles.
1. A combination of low-dose chlorpromazine and neutralizing antibodies inhibits the spread of JC virus (JCV) in a tissue culture model: implications for prophylactic and therapeutic treatment of progressive multifocal leukencephalopathy;Atwood;J. Neurovirol.,2001
2. “MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells” edited by S. Pöhlmann;Cong;PLoS One,2018
3. Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection;Dyall;Antimicrob. Agents Chemother.,2014
4. Middle East respiratory syndrome and severe acute respiratory syndrome: current therapeutic options and potential targets for novel therapies;Dyall;Drugs,2017
5. Distribution of chlorpromazine metabolites in selected organs of psychiatric patients chronically dosed up to the time of death;Forrest;Biochem. Pharmacol.,1968
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Role of the heat shock protein family in chlorpromazine‐induced cardiotoxicity;Journal of Applied Toxicology;2023-02-28
2. DRaW: prediction of COVID-19 antivirals by deep learning—an objection on using matrix factorization;BMC Bioinformatics;2023-02-15
3. Current Insights and Molecular Docking Studies of the Drugs under Clinical Trial as RdRp Inhibitors in COVID-19 Treatment;Current Pharmaceutical Design;2022-12
4. NEUROLEPTICS ATTENUATE Ca2+ RESPONSES INDUCED BY GLUTOXIM AND MOLIXAN IN MACROPHAGES;Russian Journal of Biological Physics and Chemisrty;2022-11-08
5. Chlorpromazine, a Clinically Approved Drug, Inhibits SARS-CoV-2 Nucleocapsid-Mediated Induction of IL-6 in Human Monocytes;Molecules;2022-06-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3